Y. Kim

HOXB5 Confers Tamoxifen Resistance in Breast Cancer Cells and Promotes Tumor Aggression and Progression

M. Kim, C. Y. Kim, J. Oh, 2021, AntiCancer Research.

NR4A1 Regulates Tamoxifen Resistance by Suppressing ERK Signaling in ER-Positive Breast Cancer

M. Kim, C. Y. Kim, J. Oh, 2021, Cells.

Akt1 Decreases Gcn5 Protein Stability through Regulating The Ubiquitin-Proteasome Pathway in Mouse Embryonic Fibroblasts

M. Kim, J. Oh, Y. Kim, 2022, Cell journal.

Far Beyond Cancer Immunotherapy: Reversion of Multi-Malignant Phenotypes of Immunotherapeutic-Resistant Cancer by Targeting the NANOG Signaling Axis

S. Oh, Tae Woo Kim, Y. Kim, 2020, Immune network.

Mitofusin-2 Promotes the Epithelial-Mesenchymal Transition-Induced Cervical Cancer Progression

M. Kim, Young-Min Hyun, S. Ahn, 2021, Immune network.

HOXA5 confers tamoxifen resistance via the PI3K/AKT signaling pathway in ER-positive breast cancer

M. Kim, C. Y. Kim, J. Oh, 2021, Journal of Cancer.

The homeoprotein HOXB2 limits triple-negative breast carcinogenesis via extracellular matrix remodeling

Y. Kim, Da Som Jeong, Je-Yoel Cho, 2024, International journal of biological sciences.